Sarepta Signs Gene Therapy R&D Deal for DMD – Drug Discovery & Development
|
Sarepta Signs Gene Therapy R&D Deal for DMD
Drug Discovery & Development Genethon specializes in a micro-dystrophin gene therapy approach that can target the majority of patients with DMD, according to the announcement. The organization has demonstrated proof-of-concept of their program through a robust gene expression in a … |
